| Joining the cell survival squad: an emerging role for protein kinase CK2 K Ahmed, DA Gerber, C Cochet Trends in cell biology 12 (5), 226-230, 2002 | 529 | 2002 |
| Protein kinase CK2 in health and disease: CK2: a key player in cancer biology JH Trembley, G Wang, G Unger, J Slaton, K Ahmed Cellular and molecular life sciences 66, 1858-1867, 2009 | 396 | 2009 |
| Protein kinase CK2 signal in neoplasia K Ahmed, S Tawfic, S Yu, H Wang, R Faust, A Davis Histology and histopathology 16 (2), 573-582, 2001 | 384 | 2001 |
| Protein kinase CK2–a key suppressor of apoptosis KA Ahmad, G Wang, G Unger, J Slaton, K Ahmed Advances in enzyme regulation 48 (1), 179-187, 2008 | 297 | 2008 |
| The effects of long chain fatty acids on sodium plus potassium ion-stimulated adenosine triphosphatase of rat brain K Ahmed, BS Thomas Journal of Biological Chemistry 246 (1), 103-109, 1971 | 230 | 1971 |
| Emergence of protein kinase CK2 as a key target in cancer therapy JH Trembley, Z Chen, G Unger, J Slaton, BT Kren, C Van Waes, K Ahmed Biofactors 36 (3), 187-195, 2010 | 227 | 2010 |
| Ion transport and phosphoproteins of human red cells JD Judah, K Ahmed, AEM McLean Biochim. Biophys. Acta 65 (3), 472-480, 1962 | 226 | 1962 |
| Preparation of lipoproteins containing cation-dependent ATPase K Ahmed, JD Judah Biochimica et Biophysica Acta (BBA)-General Subjects 93 (3), 603-613, 1964 | 218 | 1964 |
| The biochemistry of sodium transport JD Judah, K Ahmed Biological Reviews 39 (2), 160-193, 1964 | 194 | 1964 |
| A potential role of nuclear matrix-associated protein kinase CK2 in protection against drug-induced apoptosis in cancer cells C Guo, S Yu, AT Davis, H Wang, JE Green, K Ahmed Journal of Biological Chemistry 276 (8), 5992-5999, 2001 | 190 | 2001 |
| Elevated protein kinase CK2 activity in chromatin of head and neck tumors: association with malignant transformation RA Faust, M Gapany, P Tristani, A Davis, GL Adams, K Ahmed Cancer letters 101 (1), 31-35, 1996 | 186 | 1996 |
| Targeting CK2 for cancer therapy KA Ahmad, G Wang, J Slaton, G Unger, K Ahmed Anti-cancer drugs 16 (10), 1037-1043, 2005 | 172 | 2005 |
| Protein kinase CK2 as regulator of cell survival: implications for cancer therapy GM Unger, AT Davis, JW Slaton, K Ahmed Current cancer drug targets 4 (1), 77-84, 2004 | 162 | 2004 |
| CD66 family members are associated with tyrosine kinase activity in human neutrophils. KM Skubitz, KD Campbell, K Ahmed, AP Skubitz Journal of immunology (Baltimore, Md.: 1950) 155 (11), 5382-5390, 1995 | 156 | 1995 |
| NEK2A interacts with MAD1 and possibly functions as a novel integrator of the spindle checkpoint signaling Y Lou, J Yao, A Zereshki, Z Dou, K Ahmed, H Wang, J Hu, Y Wang, X Yao Journal of Biological Chemistry 279 (19), 20049-20057, 2004 | 155 | 2004 |
| Nuclear casein kinase 2 (CK‐2) activity in human normal, benign hyperplastic, and cancerous prostate S Yenice, AT Davis, SA Goueli, A Akdas, C Limas, K Ahmed The Prostate 24 (1), 11-16, 1994 | 152 | 1994 |
| Downregulation of CK2 induces apoptosis in cancer cells–a potential approach to cancer therapy G Wang, G Unger, KA Ahmad, JW Slaton, K Ahmed Molecular and cellular biochemistry 274, 77-84, 2005 | 147 | 2005 |
| Induction of apoptosis by antisense CK2 in human prostate cancer xenograft model JW Slaton, GM Unger, DT Sloper, AT Davis, K Ahmed Molecular Cancer Research 2 (12), 712-721, 2004 | 147 | 2004 |
| Association of elevated protein kinase CK2 activity with aggressive behavior of squamous cell carcinoma of the head and neck M Gapany, RA Faust, S Tawfic, A Davis, GL Adams, P Leder, K Ahmed Molecular medicine 1, 659-666, 1995 | 143 | 1995 |
| The effect of perceived transformational leadership style on employee engagement: The mediating effect of leader’s emotional intelligence M Milhem, H Muda, K Ahmed Foundations of Management 11 (1), 33-42, 2019 | 126 | 2019 |
Janeen H. TrembleyMinneapolis VA Health Care System and University of Minnesota在 umn.edu 的电子邮件经过验证
